CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF DRUGS AFFECTING HEMOSTASIS IN CHILDREN

dc.contributor.author	Parpieva Salima Bokijonovna
dc.date.accessioned	2025-12-31T15:39:43Z
dc.date.issued	2024-09-12
dc.description.abstract	The paper examines the safety and efficacy of using a domestic hemostatic agent, recombinant activated factor VII, coagulagil VII, and prothrombin complex concentrate, prothromplex-600 (Baxter, Austria), in neonatal and pediatric cardiac surgery. The study included 56 children aged 7 days to 5.5 years, who underwent artificial circulation surgery for congenital heart defects. Clinical and laboratory data indicate that coagulagil VII and prothromplex-600 are effective in stopping bleeding.
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/4532
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/49808
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/4532/3846
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 38 (2024): WBPH; 27-29
dc.source	2749-3644
dc.subject	Bleeding
dc.subject	prothrombin complex concentrates
dc.subject	recombinant activated factor VII
dc.title	CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF DRUGS AFFECTING HEMOSTASIS IN CHILDREN
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: bokijonovna_2024_clinical_pharmacological_approach_to_the.pdf
item.page.filesection.size: 148 KB
item.page.filesection.format: Adobe Portable Document Format